CLEVELAND – October 1, 2010 – RSB Spine, LLC, a medical device company focused on developing unique modular fusion products for surgical treatment of degenerative disc disease, today announced a 229% sales increase for the third quarter of 2010 versus third quarter 2009,and a 46% increase sequentially. Additionally, the company reported the completion of a $1.5 million private offering to expand U.S operations.

RSB Spine Chief Executive Officer John A. Redmond said: “Our master distributor, Paradigm BioDevices, continues to perform at a high level, and we expect even stronger growth going into 2011. We will be introducing several new product extensions at the North American SpineSociety meeting in Orlando next week, and the capital from our recently completed offering will help us build inventory to keep pace with the rapidly increasing demand. ”

“The InterPlate® is now the most diverse system available in the stand-alone interbody segment,” said Mike O’Neill, President of Paradigm BioDevices. “We have elevated our capabilities to a level that is beyond other products in this segment. Surgeons truly appreciate the clinicaladvantages available with our technology and the ability to use a true two-piece modular construct that can be properly coded for reimbursement.”

RSB Spine is a privately held medical device company. News releases and other information on the company are available on the Internet at: http://www.rsbspine.com

Patent Numbers 6,984,234, 7,985,255 B2, 8,100,976, 8,613,772, 6,235,034 and 9,713,537B2
Caution: Federal law restricts this device to use by or on the order of a physician.
Refer to package insert for warnings, precautions, indications, and contraindications.